pharmaphorum

AUGUST 21, 2022

There’s no word yet on its pricing, but for comparison Spravato was launched with an annual price tag of around $32,400, which the Institute for Clinical and Economic Review (ICER) concluded was around 25% to 52% too high to be cost effective.

FDA 98

FDA Labelling 98

pharmaphorum

NOVEMBER 24, 2022

Despite J&J’s high hopes for the drug, sales have remained low, not warranting a mention in any of J&J’s quarterly financial updates since launch, and the company will look to the new data to try to encourage take-up. and 17.6%, respectively, according to J&J’s pharma unit Janssen. and 14.1%, respectively.

Labelling 52

Labelling Hospitals 52

pharmaphorum

DECEMBER 2, 2020

Few companies embody the term ‘pharma giant’ as much as Pfizer. This expertise in fermentation and large-scale pharmaceutical production put Pfizer in good stead when in 1941 the US government appealed to the pharma industry for support in producing penicillin for the war effort.

Compounding 128

Compounding Vaccines Pharmaceutical Companies Pharmaceutical Companies 128

pharmaphorum

JUNE 2, 2022

Evaluate Pharma’s recent Orphan Drug Report subtitled its overview of the market ‘Niche no longer.’ This is based on the relative success orphan drugs have achieved, in terms of the number of approvals and the sales figures achieved for this area. Raising questions.

Compounding 52

Compounding Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

FEBRUARY 22, 2023

The patent battle between Amgen and Sanofi over their cholesterol-lowering antibodies has divided big pharma in the past months. Both drugs come with a high price tag. Since April 2020, Sanofi is responsible for Praluent outside of the US, while Regeneron handles its sale in the US.

FDA 104

FDA 104

pharmaphorum

MAY 17, 2021

Apellis Pharma has secured FDA approval for its complement C3 inhibitor Empaveli as a treatment for paroxysmal nocturnal hemoglobinuria (PNH) – with a label that will allow it to challenge Alexion’s established therapies directly. . billion and $1.1

FDA 52

FDA Labelling Vaccines 52

pharmaphorum

MAY 24, 2021

It is a newer concept for pharma marketers, however, who are now turning to modular solutions in response to the accelerated demand for content over the past year. Robb DeFilippis, managing director, life sciences, for end-to-end global creative production and sourcing partner Tag in the Americas agrees. About the interviewee.

Communication 102

Communication Packaging Pharmaceutical Companies Pharmaceutical Companies 102

pharmaphorum

NOVEMBER 19, 2021

So too are the sales figures. billion in vaccine sales this year. Indeed, the price tags for Pfizer’s and Moderna’s jabs are substantial. This sales strategy contrasts to AstraZeneca, which pledged to provide its vaccine on a not-for-profit basis until the pandemic ends. billion in covid vaccine sales in 2021.

Vaccines 137

Vaccines Communication 137

Pharma Marketing Network

OCTOBER 4, 2020

Don ( PMN): Hello everyone thanks for joining us at the Pharma marketing podcast. Don (PMN): Alright welcome back to the Pharma marketing podcast, I’m here with our guest Vlad Mkrtumyan of Logic Inbound and Author of the Doctor’s Guide to SEO. I’m your host Don Langsdorf our guest today is Vlad Mkrtumyan.

Health and Personal Care Stores 52

Health and Personal Care Stores Packaging 52

pharmaphorum

FEBRUARY 26, 2021

By most measures the single largest pharma company in the world, US-based Johnson & Johnson (J&J) is also arguably one of the most well-known drugmakers among the general public. . Johnson’s Baby Powder also went on sale during this year and was extremely successful.

Vaccines 126

Vaccines Labelling Communication 126

pharmaphorum

AUGUST 26, 2022

BioMarin Pharma has its landmark first approval for Roctavian – the first for a haemophilia gene therapy – and will now have to see if that can convert that into a viable business in Europe. million spread over five years.

FDA 111

FDA 111

pharmaphorum

JUNE 15, 2021

The adoption of New Science – a unique combination of the best in science and health technology that address significant unmet patient needs – is delivering more precise and effective treatments, but often at a higher price tag, according to new research. And 65% of pharma sales rep meetings were held virtually.

Vaccines 90

Vaccines 90

Pharma Marketing Network

JUNE 8, 2020

This is Don Langsdorf with the Pharma Marketing Network pleased to welcome today Dave Chase, co-founder of the Health Rosetta. I mean probably the only real exception is in specialty pharma in terms of, underlying cost actually having gone up. Don (PMN): Hi welcome. Good morning, Dave. Dave (HR): Sure. Thanks for having me on.

Health and Personal Care Stores 40

Health and Personal Care Stores Hospitals Mayo Clinic Specialty Pharmacies 40